Methylnaltrexone use in patient with opiod induced constipation – case report

Tomasz Dzierżanowski

eISSN: 2081-2833
ISSN: 2081-0016

Medycyna Paliatywna/Palliative Medicine

Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures

Editorial System

Submit your Manuscript

1/2009
vol. 1

Send email

Copy url:

abstract:

Case report

Methylnaltrexone use in patient with opiod induced constipation – case report

Tomasz Dzierżanowski

Medycyna Paliatywna 2009; 1: 53-56

Online publish date: 2009/11/26

View full text Get citation

Constipation in palliative care patients has multifactor aetiology. In this case report, the author raises the problem of constipation appearing in an opioid-treated patient in spite of prophylactic means applied. Subcutaneous methylnaltrexone was used, but the first dose proved unsuccessful. Regular bowel movements started after the second dose. Attention has been drawn to difficulties in the treatment of opioid-induced constipation, when in some cases the use of more than one dose of methylnaltrexone may prove necessary to reverse a constipating effect of opioids and maintain effective bowel movements.

keywords:

Methylnaltrexone use in patient with opiod induced constipation – case report

Tomasz Dzierżanowski

opioid-induced constipation, opioid antagonists, methylnaltrexone